Plain-English translation of NCT06553885 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new medication called for people who have advanced colorectal cancer or hepatocellular carcinoma (liver cancer) that has continued to grow despite previous treatments. The medication is given as an infusion into the vein three times per month, and researchers want to see if this treatment can help slow or stop cancer growth.
People with advanced colorectal cancer and liver cancer often run out of effective treatment options after standard therapies stop working. This trial is exploring whether this medication could offer hope to patients who have exhausted other treatment paths.
You likely qualify if…
You likely don't qualify if…
You would receive the medication as an intravenous infusion (through a vein in your arm) on days 1, 8, and 15 of each 28-day cycle. Each infusion takes about 30 minutes. You'll have regular clinic visits for blood tests and imaging scans to check how your cancer is responding to the treatment. Participation continues until the medication stops working or side effects become too difficult to manage.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States